CINDY PONTIOUS: Open Payments
NPI 1770925935 · WEST DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$657 in 32 payments from 9 companies in 2025. Trend: 2023 $379 · 2024 $339 · 2025 $657
Food & beverage: $657
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 9 | $198 |
| ABBVIE INC. | 10 | $189 |
| Teva Pharmaceuticals USA, Inc. | 3 | $78 |
| Lundbeck LLC | 3 | $69 |
| Vanda Pharmaceuticals Inc. | 2 | $37 |
| Alkermes, Inc. | 2 | $33 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
Products named: REXULTI, VRAYLAR, UZEDY, ABILIFY ASIMTUFII, FANAPT, ARISTADA, INVEGA SUSTENNA, ABILIFY MAINTENA.
Industry payments across IA — which companies pay providers there.
